The recall involves levothyroxine sodium tablets that are used to treat hypothyroidism and decrease the size of enlarged thyroid glands, according to Mayo Clinic.
The Food and Drug Administration has recalled a commonly prescribed thyroid medication.
The recall involves levothyroxine sodium tablets that are used to treat hypothyroidism and decrease the size of enlarged thyroid glands, according to Mayo Clinic.
The FDA said they had been functioning as “subpotent drugs,” meaning they had less of an active ingredient and were ultimately less effective.
Major Pharmaceuticals packaged and distributed the recalled tablets, while Cardinal Health also distributed some of the recalled products.
Twelve different dosages and cartons from the two companies were listed in the FDA’s recall notice. You can read the full list here.
The recalled drugs were distributed nationwide, but the FDA did not specify the number of recalled tablets
The FDA issued a Class II recall on July 13. A Class II recall means the involved products “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
